BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 4382749)

  • 1. Spectral studies of drug interaction with hepatic microsomal cytochrome.
    Schenkman JB; Remmer H; Estabrook RW
    Mol Pharmacol; 1967 Mar; 3(2):113-23. PubMed ID: 4382749
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the relationship between the effects of various substances on absorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsomes.
    Sasame HA; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):123-30. PubMed ID: 4389182
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.
    Gigon PL; Gram TE; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):109-22. PubMed ID: 4389181
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid hormone and activities of drug-metabolizing enzymes and electron transport systems of rat liver microsomes.
    Kato R; Takahashi A
    Mol Pharmacol; 1968 Mar; 4(2):109-20. PubMed ID: 5645609
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of toxohormone on microsomal cytochromes and hydroxylating systems of rat liver.
    Takahashi A; Kato R
    J Biochem; 1969 Feb; 65(2):325-7. PubMed ID: 5771959
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of drugs in old rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of old rats.
    Kato R; Takanaka A
    Jpn J Pharmacol; 1968 Dec; 18(4):381-8. PubMed ID: 4388257
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible role of P-450 in the oxidation of drugs in liver microsomes.
    Kato R
    J Biochem; 1966 Jun; 59(6):574-83. PubMed ID: 4381416
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and cytochrome P-450 binding spectra of (+)- and (-)-hexobarbital in rat liver microsomes.
    Degkwitz E; Ullrich V; Staudinger H
    Hoppe Seylers Z Physiol Chem; 1969 May; 350(5):547-53. PubMed ID: 4389286
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.
    Marietta MP; Vesell ES; Hartman RD; Weisz J; Dvorchik BH
    J Pharmacol Exp Ther; 1979 Feb; 208(2):271-9. PubMed ID: 33263
    [No Abstract]   [Full Text] [Related]  

  • 10. EPR measurements of substrate interaction with cytochrome P-450.
    Cammer W; Schenkman JB; Estabrook RW
    Biochem Biophys Res Commun; 1966 May; 23(3):264-8. PubMed ID: 4289726
    [No Abstract]   [Full Text] [Related]  

  • 11. The aniline hydroxylase and nitroreductase activities of partially purified cytochromes P-450 and P-420, and cytochrome b5 solubilized from rabbit hepatic microsomes.
    Symms KG; Juchau MR
    Drug Metab Dispos; 1974; 2(2):194-201. PubMed ID: 4151000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hydroxylase activity and hemoprotein content of microsomes from rabbit liver].
    Lange G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(3):221-38. PubMed ID: 4385653
    [No Abstract]   [Full Text] [Related]  

  • 13. Reaction of drugs with microsomal liver hydroxylase: its influence on drug action.
    Remmer H; Estabrook RW; Schenkman J; Greim H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):98-116. PubMed ID: 4173846
    [No Abstract]   [Full Text] [Related]  

  • 14. Further studies on the metabolism of drugs by subfractions of hepatic microsomes. 3. Effects of the NADPH-generating system.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1967 Nov; 158(2):317-22. PubMed ID: 4383639
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of carbon tetrachloride induced progressive liver damage on drug-metabolizing enzymes and cytochrome P-450 in rat liver.
    Vorne M; Arvela P
    Acta Pharmacol Toxicol (Copenh); 1971; 29(5):417-27. PubMed ID: 4399007
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of sex difference in drug-oxidizing activity of liver microsomes.
    Kato R; Takanaka A; Takayanagi M
    Jpn J Pharmacol; 1968 Dec; 18(4):482-9. PubMed ID: 4388258
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of drug substrates on the reduction of hepatic microsomal cytochrome P-450 by NADPH.
    Gigon PL; Gram TE; Gillette JR
    Biochem Biophys Res Commun; 1968 May; 31(4):558-62. PubMed ID: 4385338
    [No Abstract]   [Full Text] [Related]  

  • 18. [Change in the affinity of isolated liver microsomes for aniline, N-ethylaniline, oxygen, ethyl isocyanide and carbon monoxide by the treatment of young rabbits with phenobarbital].
    Kröber F; Lange G; Mathes S; Mor G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):161-3. PubMed ID: 4239199
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation.
    Lu AY; Strobel HW; Coon MJ
    Biochem Biophys Res Commun; 1969 Aug; 36(4):545-51. PubMed ID: 4390187
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on microsomal enzyme activities (coumarin hydroxylation, NADP-oxidation, glucose-6-phosphatase and esterase) and cytochrome content (P-450 and b5) in normal, scorbutic and starved guinea pigs].
    Degkwitz E; Luft D; Pfeiffer U; Staudinger H
    Hoppe Seylers Z Physiol Chem; 1968 Apr; 349(4):465-71. PubMed ID: 4385906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.